000538 云南白药
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额4,106,0394,599,6944,297,0033,502,7423,209,410
投资活动产生之现金流量净额(584,686)(1,985,337)(1,199,001)518,581(6,316,083)
筹资活动产生之现金流量净额(3,042,217)(4,348,992)(6,977,735)(2,918,042)(2,733,304)
汇率变动对现金及现金等价物的影响(10,320)(8,662)3,4972,32516,272
现金及现金等价物净增加/(减少)468,816(1,743,297)(3,876,236)1,105,605(5,823,705)
期初现金及现金等价物余额8,532,23310,275,53014,151,76513,046,16018,869,865
期末现金及现金等价物余额9,001,0498,532,23310,275,53014,151,76513,046,160